Search

Your search keyword '"MESH: SARS-CoV-2"' showing total 187 results

Search Constraints

Start Over You searched for: Descriptor "MESH: SARS-CoV-2" Remove constraint Descriptor: "MESH: SARS-CoV-2"
187 results on '"MESH: SARS-CoV-2"'

Search Results

1. Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population

2. Changes over time in anxiety, depression, and stress symptoms among healthcare workers in French emergency departments during the first COVID-19 outbreak

3. The role of berberine in Covid-19: potential adjunct therapy

4. Semen Cryopreservation in Adolescents and Young Adults with Hematologic Diseases: from Bed to Benchside

5. Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial

6. Type I interferons and SARS-CoV-2: from cells to organisms

7. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

8. SARS-CoV-2 spike protein removes lipids from model membranes and interferes with the capacity of high density lipoprotein to exchange lipids

9. Management of anaphylaxis due to COVID-19 vaccines in the elderly

10. Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021

11. Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine

12. Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa

13. Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager

14. Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination

15. Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S COCOPREV study)

16. Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with <scp>non‐Hodgkin</scp> lymphoma treated with B‐cell depleting immunotherapy

17. Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2

18. COVID-19 pandemic

19. In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect

20. Efficacy of Chest CT for COVID-19 Pneumonia Diagnosis in France

21. Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021

22. Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

23. Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workers

24. The Pathophysiology of Long COVID throughout the Renin-Angiotensin System

25. Impact of the COVID-19 crisis on healthcare workers: The need to address quality of working life issues

26. Surveillance of Viral Encephalitis in the Context of COVID-19: A One-Year Observational Study among Hospitalized Patients in Dakar, Senegal

27. Bat coronaviruses related to SARS-CoV-2 and infectious for human cells

28. Association between growth of the SARS-CoV-2 epidemic and increased coughing rate in cold temperatures: surveillance in Hokkaido, Japan

29. The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors

30. Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome

31. The relationship between COVID‐19 viral load and disease severity: A systematic review

32. Use of psychoactive substances by night-shift hospital healthcare workers during the first wave of the COVID-19 pandemic: a cross-sectional study based in Parisian public hospitals (ALADDIN)

33. Atypical clinical presentation of COVID-19 infection in residents of a long-term care facility

34. Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China

35. Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine

36. Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection

37. Severe relapse of SARS‐CoV‐2 infection in a kidney transplant recipient with negative nasopharyngeal SARS‐CoV‐2 RT‐PCR after rituximab

38. Antibodies Targeting KSHV gH/gL Reveal Distinct Neutralization Mechanisms

39. Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort

40. Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk

41. Residential Mobility of a Cohort of Homeless People in Times of Crisis: COVID-19 Pandemic in an European Metropolis

42. Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels

43. GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults

44. Conditionality of COVID-19 vaccine acceptance in European countries

45. Heterologous ChAdOx1-S/BNT162b2 Vaccination: Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

46. Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review

47. Nicotinic receptors as SARS-CoV-2 spike co-receptors?

48. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

49. Mechanical complications in ST-elevation myocardial infarction: The impact of pre-hospital delay

50. Can antidepressants unlock prescription of rimonabant in the fight against COVID-19?

Catalog

Books, media, physical & digital resources